These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 30149038

  • 1. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N, Shum D, König A, Kim H, Heo J, Min S, Lee J, Ko Y, Choi I, Lee H, Radu C, Hoenen T, Min JY, Windisch MP.
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [Abstract] [Full Text] [Related]

  • 2. Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.
    Biedenkopf N, Hoenen T.
    Methods Mol Biol; 2017 Oct; 1628():119-131. PubMed ID: 28573615
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [Abstract] [Full Text] [Related]

  • 4. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
    Hoenen T, Groseth A, Callison J, Takada A, Feldmann H.
    Antiviral Res; 2013 Sep; 99(3):207-13. PubMed ID: 23751367
    [Abstract] [Full Text] [Related]

  • 5. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
    Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflubé LR, Ruedas JB, Connor JH, Ebihara H, Mühlberger E.
    Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
    [Abstract] [Full Text] [Related]

  • 6. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA, Barnes AB, Wiehle RD, Fontenot GK, Hoenen T, White JM.
    Viruses; 2016 Aug 02; 8(8):. PubMed ID: 27490565
    [Abstract] [Full Text] [Related]

  • 7. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y, Cui R, Li G, Gao Q, Yuan S, Altmeyer R, Zou G.
    Antiviral Res; 2016 Jan 02; 125():1-7. PubMed ID: 26585243
    [Abstract] [Full Text] [Related]

  • 8. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
    Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L.
    Viruses; 2018 Nov 30; 10(12):. PubMed ID: 30513600
    [Abstract] [Full Text] [Related]

  • 9. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR, Guerrero LW, Chakrabarti AK, McMullan LK, Flint M, Bluemling GR, Painter GR, Nichol ST, Spiropoulou CF, Albariño CG.
    Antiviral Res; 2016 Dec 30; 136():9-18. PubMed ID: 27771389
    [Abstract] [Full Text] [Related]

  • 10. A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.
    Martin S, Chiramel AI, Schmidt ML, Chen YC, Whitt N, Watt A, Dunham EC, Shifflett K, Traeger S, Leske A, Buehler E, Martellaro C, Brandt J, Wendt L, Müller A, Peitsch S, Best SM, Stech J, Finke S, Römer-Oberdörfer A, Groseth A, Feldmann H, Hoenen T.
    Genome Med; 2018 Aug 07; 10(1):58. PubMed ID: 30081931
    [Abstract] [Full Text] [Related]

  • 11. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
    Li D, Chen T, Hu Y, Zhou Y, Liu Q, Zhou D, Jin X, Huang Z.
    J Virol; 2016 Oct 01; 90(19):8720-8. PubMed ID: 27440895
    [Abstract] [Full Text] [Related]

  • 12. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE, Fénéant L, Szymańska-de Wijs KM, Kessler NP, Nelson EA, Shoemaker CJ, Schmaljohn CS, Polyak SJ, White JM.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30700611
    [Abstract] [Full Text] [Related]

  • 13. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.
    J Infect Dis; 2015 Oct 01; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [Abstract] [Full Text] [Related]

  • 14. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
    Tshiani Mbaya O, Mukumbayi P, Mulangu S.
    Front Immunol; 2021 Oct 01; 12():721328. PubMed ID: 34526994
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM, Dyall J, DeWald LE, King SR, Dube D, Legendre M, Nelson E, Drews KC, Gross R, Gerhardt DM, Torzewski L, Postnikova E, Liang JY, Ban B, Shetty J, Hensley LE, Jahrling PB, Olinger GG, White JM, Markovitz DM.
    PLoS Negl Trop Dis; 2019 Jul 01; 13(7):e0007595. PubMed ID: 31356611
    [Abstract] [Full Text] [Related]

  • 16. A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.
    Wang Z, Li J, Fu Y, Zhao Z, Zhang C, Li N, Li J, Cheng H, Jin X, Lu B, Guo Z, Qian J, Liu L.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772717
    [Abstract] [Full Text] [Related]

  • 17. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
    Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T.
    J Virol; 2014 Sep 16; 88(18):10511-24. PubMed ID: 24965473
    [Abstract] [Full Text] [Related]

  • 18. Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.
    Du X, Zuo X, Meng F, Wu F, Zhao X, Li C, Cheng G, Qin FX.
    Biochem Biophys Res Commun; 2020 Feb 19; 522(4):862-868. PubMed ID: 31806372
    [Abstract] [Full Text] [Related]

  • 19. Ebola Virus Entry: From Molecular Characterization to Drug Discovery.
    Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palù G.
    Viruses; 2019 Mar 19; 11(3):. PubMed ID: 30893774
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.
    Falzarano D.
    Methods Mol Biol; 2017 Mar 19; 1628():203-210. PubMed ID: 28573622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.